SERIES B PREFERRED STOCK TERM SHEET

Company:          NovaBridge AI, Inc. (Delaware C-Corp)
Investors:        Horizon Ventures (Lead), Catalyst Capital, Redwood Partners
Round Size:       $35,000,000
Pre-Money Valuation: $140,000,000
Post-Money Valuation: $175,000,000
Date:             August 20, 2025
Status:           Non-Binding (except Confidentiality, Exclusivity, Expenses)

SECURITIES AND PRICING

  Security: Series B Preferred Stock
  Price per share: $8.75 (based on 16,000,000 Series B shares)
  Authorized shares post-round: 20,000,000 Series B Preferred

INVESTMENT AMOUNTS

  Horizon Ventures:    $20,000,000  (2,285,714 shares)
  Catalyst Capital:    $10,000,000  (1,142,857 shares)
  Redwood Partners:     $5,000,000  (  571,429 shares)

CAPITALIZATION (Post-Closing)

  Founders & Common:     10,000,000 shares  (50.0%)
  Series A Preferred:     4,000,000 shares  (20.0%)
  Series B Preferred:     4,000,000 shares  (20.0%)
  ESOP (unallocated):     2,000,000 shares  (10.0%)
  Total Fully Diluted:   20,000,000 shares

LIQUIDATION PREFERENCE
  1× non-participating preferred. Series B has senior liquidation preference
  over Series A and Common. Upon a Deemed Liquidation Event, Series B holders
  receive the greater of (i) 1× their Original Purchase Price plus declared
  but unpaid dividends, or (ii) their pro-rata share on an as-converted basis.

ANTI-DILUTION
  Broad-based weighted average anti-dilution protection.

DIVIDENDS
  Non-cumulative, 6% per annum when and if declared by the Board.
  Participation pari passu with Common on an as-converted basis.

CONVERSION
  Automatic conversion to Common upon (a) IPO with gross proceeds ≥ $75M and
  per-share price ≥ 3× Series B price, or (b) written consent of 60% of
  Series B holders. Optional conversion at any time at holder's election.

VOTING RIGHTS
  One vote per share on an as-converted basis. Series B votes as a separate
  class on: (i) amendments to Series B terms, (ii) issuance of senior or
  pari passu securities, (iii) dividends or redemptions, (iv) changes to
  Board size.

BOARD COMPOSITION
  5 directors:
    2 — Common holders (Founders)
    2 — Series B (1 Horizon, 1 Catalyst)
    1 — Independent (mutually agreed)

PROTECTIVE PROVISIONS (Series B Consent Required)
  - Any liquidation, merger, or sale of substantially all assets
  - Debt exceeding $2,000,000
  - Related-party transactions > $250,000
  - Changes to authorized share count
  - Annual budget approval (if not adopted by Dec 31)

RIGHT OF FIRST REFUSAL & CO-SALE
  Pro-rata right of first refusal on new issuances. Co-sale right on
  founder transfers exceeding 5% of holdings per 12-month period.

DRAG-ALONG
  If holders of 60% of Preferred and a majority of Common approve a sale,
  all stockholders must participate on the same terms.

INFORMATION RIGHTS
  Monthly financial statements (within 30 days), annual audited financials
  (within 90 days), annual budget. Inspection rights with 5 business days notice.

VESTING
  Founder shares: 4-year vesting, 1-year cliff, monthly thereafter.
  Acceleration: 50% single-trigger on Change of Control; 100% double-trigger.

EXCLUSIVITY
  45 days from execution of this term sheet.

EXPENSES
  Company to reimburse lead investor legal fees up to $75,000.

GOVERNING LAW
  State of Delaware.
